96
Participants
Start Date
November 30, 2008
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
Warfarin (Coumadin)
Days -6 and -5: 10 mg warfarin (Coumadin) once daily, dosage lower if the INR is already high on day -5; Days -4 to -1 (could be prolonged by two days): 2.5, 5, 10, 12.5 or 15 mg warfarin (Coumadin) once daily, dosage depending on INR
Rivaroxaban (Xarelto, BAY59-7939)
Days 0 to 3: 20 mg rivaroxaban once daily
Placebo
Days 0 to 3: 1 tablet placebo, identical to active tablet
Vitamin K (Konakion)
Day 5: 10 mg vitamin K (Konakion) once daily
Mönchengladbach
Cologne
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
Bayer
INDUSTRY